follow @ClinPsychNews
RSS Feeds
Find Us on Facebook

Schizophrenia and Psychosis

Depressive Symptoms Common, Neglected in Early Schizophrenia

By: SHARON WORCESTER, Clinical Psychiatry News Digital Network

01/23/12

FROM SCHIZOPHRENIA RESEARCH

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

Vitals

Major Finding: Of 405 patients with an available baseline Clinical Global Impressions-Severity of Illness Scale-Bipolar Illness (CGI-BP) depression score, 106 (26.2%) had moderate to severe depressive symptoms at service entry.

Data Source: A medical file audit.

Disclosures: This study was supported by grants from Eli Lilly & Co. Australia and the Leenaards Foundation, Switzerland. Dr. Cotton is supported by the Ronald Phillip Griffith Fellowship, the University of Melbourne. Several other study authors reported that they serve on Eli Lilly’s speakers board.

Depressive symptoms are common and tend to be neglected in patients with first episode schizophrenia spectrum disorders, according to a medical file audit involving records for more than 400 patients.

Of 405 patients with an available baseline Clinical Global Impressions-Severity of Illness Scale-Bipolar Illness (CGI-BP) depression score, 106 (26.2%) had moderate to severe depression at service entry, Sue M. Cotton, Ph.D., of the University of Melbourne, and her colleagues report in the January issue of Schizophrenia Research.

Among the characteristics of patients with moderate to severe depression at service entry, compared with those without depressive symptoms, were a significantly greater likelihood of a past history of major depressive disorder (MDD; odds ratio, 2.58) and suicide attempts (OR, 1.55), a family history of psychiatric disorder (OR, 1.40), and significantly reduced likelihood of a past history of substance use disorder (OR, 0.67), the investigators found (Schizophr. Research 2012;134:20-6).

The patients with depressive symptoms also were more likely to have current MDD (OR, 5.52), and to have partial/full insight into their psychotic disorder (OR, 0.68), and they were less likely to have a current substance use disorder (OR, 0.65).

During treatment they were less likely to be admitted to the hospital (OR, 0.79), with a lower number of admission (OR, 0.84), and were less likely to be using substances (OR, 0.40).At discharge they were more likely to be depressed and to have partial/full insight to their illness (OR, 2.04 and 0.70, respectively), the investigators said.

Data on antidepressant medication use were available for 254 patients, and of those with moderate to severe depressive symptoms, 45 (55.6%) were prescribed antidepressants; these patients had significantly higher CGI-BP depression scores than did those with depressive symptoms who were not prescribed antidepressants.

The audit also provided descriptive characteristics of the 15 patients with persistent depressive symptoms and the 91 without persistent depressive symptoms (of the 105 patients with moderate to severe depressive symptoms at service entry). For example, those with persistent symptoms were significantly more likely to have a past diagnosis of personality disorder, as well as a diagnosis of a personality disorder at service entry (OR, 10.88 and 3.81, respectively).

Personality disorder diagnoses at service entry included borderline personality disorder, schizotypal, antisocial personality disorder, and personality disorder not otherwise specified.

Patients with persistent depression were also significantly more likely to have a past history of suicide attempts as compared with the two other groups (OR, 2.54).

Those patients with persistent depression had a shorter duration of treatment, all were noncompliant with treatment, and they were more likely to have ongoing substance use. At discharge, they had a significantly higher CGI symptom severity score, a lower global assessment of functioning mean score, and were less likely to be working, the investigators noted.

Of 81 patients with depression for whom antidepressant treatment information was available, 4 had persistent depressive symptoms and 77 did not. All four of those with persistent symptoms received treatment, and 41 of those without persistent symptoms received treatment.

The findings regarding the prevalence of depressive symptoms support the notion that the condition is common in early schizophrenia, and the fact that only about 29% of those with depressive symptoms had a comorbid clinical diagnosis of major depressive disorder at service entry might reflect underdiagnosis or underreporting of MDD. That finding also might be a sign that depressive symptoms are neglected in first episode of schizophrenia (FES) treatment, with more emphasis being placed on management of positive and negative symptoms, the investigators suggested.

> more Schizophrenia and Psychosis articles


I would like to receive Clinical Psychiatry News E-Newsletter The Cognoscenti each week.


Specialty Focus
Sponsored by


Schizophrenia and Psychosis RSS

Interested in being notified of new Schizophrenia and Psychosis news?

Click here to view our Schizophrenia and Psychosis RSS Feed.

 

calendar
May 24 - 27
Chicago, IL
Association for Psychological Science (APS): Annual Convention
May 29 - Jun 1
Phoenix, AZ
National Institute of Mental Health (NIMH): New Clinical Drug Evaluation Unit (NCDEU)
Jun 3 - 7
Stockholm,
Collegium Internationale Neuro-Psychopharmacologicum (CINP): World Congress
Jun 5 - 10
Kona, HI
International Behavioral Neuroscience Society (IBNS): Annual Meeting
Jun 12 - 17
Chicago, IL
American Psychoanalytic Association (APsaA): 101st Annual Meeting
Jun 18 - 26
Rapid City, SD
Reclaiming Youth International: 19th Annual Black Hills Seminars
Jun 23 - 27
San Francisco, CA
Research Society on Alcoholism (RSA): Annual Scientific Conference
Jul 10 - 13
Liverpool,
Royal College of Psychiatrists: Annual Meeting
Jul 21 - 28
Dpart Venice,
Primary Care: Mental Health Issues with a Focus on Drugs and Behavior
Jul 21 - 25
Paris,
International Association for Child & Adolescent Psych & Allied Professions (IACAPAP): World Congress
More Calendar »